Correction notice to “Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model”
Guardado en:
Autores principales: | Chiao-Fang Teng, Ting Wang, Tzu-Hua Wu, Jia-Hui Lin, Fu-Ying Shih, Woei-Cherng Shyu, Long-Bin Jeng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bf8c42f1b0dc4d5fba2ea0767ad4ec26 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model
por: Chiao-Fang Teng, et al.
Publicado: (2020) -
A Next-Generation Sequencing-Based Platform for Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma of Hepatocellular Carcinoma Patients
por: Chiao-Fang Teng, et al.
Publicado: (2018) -
Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
por: Nicola Personeni, et al.
Publicado: (2021) -
Checkpoint inhibition through small molecule-induced internalization of programmed death-ligand 1
por: Jang-June Park, et al.
Publicado: (2021) -
Lenvatinib Plus Immune Checkpoint Inhibitors Improve Survival in Advanced Hepatocellular Carcinoma: A Retrospective Study
por: Xiaozhun Huang, et al.
Publicado: (2021)